XML 37 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2013
FAIR VALUE OF FINANCIAL INSTRUMENTS  
Schedule of carrying value and estimated fair value, as well as the respective hierarchy classifications, of the financial assets and liabilities that are not carried at estimated fair value

The following table presents the carrying value and estimated fair value, as well as the respective hierarchy classifications, of the Company’s financial assets and liabilities that are not carried at estimated fair value (excluding financial instruments which are carried at estimated fair value on a recurring basis) as of March 31, 2013 (amounts in thousands):

 

 

 

As of March 31, 2013

 

Fair Value Hierarchy

 

 

 

Carrying
Amount

 

Estimated
Fair Value

 

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

 

Significant Other
Observable
Inputs (Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

Cash, restricted cash, and cash equivalents

 

$

1,435,264

 

$

1,435,264

 

$

1,435,264

 

$

 

$

 

Corporate loans, net of allowance for loan losses of $206,227 as of March 31, 2013(1)

 

5,687,728

 

5,800,465

 

 

5,360,906

 

439,559

 

Corporate loans held for sale(1)

 

107,395

 

130,720

 

 

107,356

 

23,364

 

Private equity investments, at cost(2)

 

405

 

2,115

 

 

 

2,115

 

Other assets

 

8,452

 

8,287

 

 

8,287

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Collateralized loan obligation secured debt

 

$

5,058,520

 

$

4,972,006

 

$

 

$

 

$

4,972,006

 

Collateralized loan obligation junior secured notes to affiliates

 

193,921

 

188,753

 

 

 

188,753

 

Credit facilities

 

46,089

 

46,089

 

 

 

46,089

 

Senior notes

 

362,202

 

429,157

 

429,157

 

 

 

Junior subordinated notes

 

283,517

 

134,351

 

 

 

134,351

 

 

(1)                                 Corporate loans held for investment are carried at amortized cost net of allowance for loan losses, while corporate loans held for sale are carried at the lower of cost or estimated fair value. Refer to “Fair Value Measurements” below for a table presenting the corporate loans which are measured at fair value on a non-recurring basis.

 

(2)                                 Included within other assets on the condensed consolidated balance sheets.

 

The following table presents the carrying value and estimated fair value, as well as the respective hierarchy classifications, of the Company’s financial assets and liabilities that are not carried at estimated fair value (excluding financial instruments which are carried at estimated fair value on a recurring basis) as of December 31, 2012 (amounts in thousands):

 

 

 

As of December 31, 2012

 

Fair Value Hierarchy

 

 

 

Carrying
Amount

 

Estimated
Fair Value

 

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

 

Significant Other
Observable
Inputs (Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

Cash, restricted cash, and cash equivalents

 

$

1,134,002

 

$

1,134,002

 

$

1,134,002

 

$

 

$

 

Corporate loans, net of allowance for loan losses of $223,472 as of December 31, 2012

 

5,783,689

 

5,831,218

 

 

5,203,763

 

627,455

 

Corporate loans held for sale(1)

 

128,289

 

195,078

 

 

151,327

 

43,751

 

Private equity investments, at cost(2)

 

405

 

1,635

 

 

 

1,635

 

Other assets

 

17,148

 

16,777

 

 

16,439

 

338

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Collateralized loan obligation secured debt

 

$

5,122,338

 

$

5,020,115

 

$

 

$

 

$

5,020,115

 

Collateralized loan obligation junior secured notes to affiliates

 

296,557

 

290,948

 

 

 

290,948

 

Credit facilities

 

107,789

 

107,789

 

 

 

107,789

 

Convertible senior notes

 

166,028

 

268,238

 

 

268,238

 

 

Senior notes

 

362,178

 

412,126

 

412,126

 

 

 

Junior subordinated notes

 

283,517

 

134,351

 

 

 

134,351

 

 

(1)                                 Corporate loans held for sale are carried at the lower of cost or estimated fair value. Refer to “Fair Value Measurements” below for a table presenting the corporate loans held for sale which are measured at fair value on a non-recurring basis.

 

(2)                                Included within other assets on the consolidated balance sheets.

Schedule of fair value of financial assets and liabilities measured on a recurring basis

The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of March 31, 2013, and indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value (amounts in thousands):

 

 

 

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

 

Significant
Other
Observable
Inputs (Level 2)

 

Significant
Unobservable Inputs
(Level 3)

 

Balance as of
March 31, 2013

 

Assets:

 

 

 

 

 

 

 

 

 

Securities:

 

 

 

 

 

 

 

 

 

Securities available-for-sale

 

$

 

$

316,882

 

$

42,083

 

$

358,965

 

Other securities, at estimated fair value

 

 

52,966

 

3,237

 

56,203

 

Residential mortgage-backed securities

 

 

 

87,028

 

87,028

 

Total securities

 

 

369,848

 

132,348

 

502,196

 

Corporate loans, at estimated fair value

 

 

25,716

 

17,325

 

43,041

 

Equity investments, at estimated fair value

 

28,428

 

54,357

 

102,262

 

185,047

 

Derivatives:

 

 

 

 

 

 

 

 

 

Foreign exchange options

 

 

 

5,581

 

5,581

 

Commodity swaps

 

 

6,073

 

 

6,073

 

Common stock warrants

 

1,651

 

 

1,819

 

3,470

 

Foreign exchange forward contracts

 

 

6,514

 

 

6,514

 

Credit default swaps—protection purchased

 

 

56

 

 

56

 

Total derivatives

 

1,651

 

12,643

 

7,400

 

21,694

 

Other assets:

 

 

 

 

 

 

 

 

 

Interests in joint ventures and partnerships

 

 

 

169,931

 

169,931

 

Other assets

 

 

406

 

 

406

 

Total other assets

 

 

406

 

169,931

 

170,337

 

Total

 

$

30,079

 

$

462,970

 

$

429,266

 

$

922,315

 

Liabilities:

 

 

 

 

 

 

 

 

 

Securities sold, not yet purchased

 

$

1,235

 

$

 

$

 

$

1,235

 

Derivatives:

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

 

79,445

 

 

79,445

 

Foreign exchange forward contracts

 

 

14,515

 

 

14,515

 

Credit default swaps—protection purchased

 

 

858

 

 

858

 

Commodity swaps

 

 

5,127

 

 

5,127

 

Foreign exchange options

 

 

 

231

 

231

 

Total derivatives

 

 

99,945

 

231

 

100,176

 

Total

 

$

1,235

 

$

99,945

 

$

231

 

$

101,411

 

 

The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2012 and indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value (amounts in thousands):

 

 

 

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

 

Significant
Other
Observable
Inputs (Level 2)

 

Significant
Unobservable Inputs
(Level 3)

 

Balance as of
December 31, 2012

 

Assets:

 

 

 

 

 

 

 

 

 

Securities:

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

 

$

370,072

 

$

42,221

 

$

412,293

 

Other securities, at estimated fair value

 

 

34,476

 

2,909

 

37,385

 

Residential mortgage-backed securities

 

 

 

83,842

 

83,842

 

Total securities

 

 

404,548

 

128,972

 

533,520

 

Corporate loans, at estimated fair value

 

 

19,738

 

16,141

 

35,879

 

Equity investments, at estimated fair value

 

23,790

 

40,085

 

97,746

 

161,621

 

Derivatives:

 

 

 

 

 

 

 

 

 

Foreign exchange options

 

 

 

8,562

 

8,562

 

Commodity swaps

 

 

8,557

 

 

8,557

 

Common stock warrants

 

1,744

 

 

1,574

 

3,318

 

Foreign exchange forward contracts

 

 

2,615

 

 

2,615

 

Credit default swaps—protection sold

 

 

19

 

 

19

 

Credit default swaps—protection purchased

 

 

136

 

 

136

 

Total derivatives

 

1,744

 

11,327

 

10,136

 

23,207

 

Other assets:

 

 

 

 

 

 

 

 

 

Interests in joint ventures and partnerships

 

 

 

142,477

 

142,477

 

Other assets

 

 

319

 

 

319

 

Total other assets

 

 

319

 

142,477

 

142,796

 

Total

 

$

25,534

 

$

476,017

 

$

395,472

 

$

897,023

 

Liabilities:

 

 

 

 

 

 

 

 

 

Securities sold, not yet purchased

 

$

1,158

 

$

 

$

 

$

1,158

 

Derivatives:

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

 

90,618

 

 

90,618

 

Foreign exchange forward contracts

 

 

23,590

 

 

23,590

 

Credit default swaps—protection purchased

 

 

1,276

 

 

1,276

 

Commodity swaps

 

 

1,501

 

 

1,501

 

Foreign exchange options

 

 

 

285

 

285

 

Total derivatives

 

 

116,985

 

285

 

117,270

 

Total

 

$

1,158

 

$

116,985

 

$

285

 

$

118,428

 

Schedule of fair value of assets measured on a non-recurring basis

The following table presents information about the Company’s assets measured at fair value on a non-recurring basis as of March 31, 2013, and indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value (amounts in thousands). There were no liabilities measured at fair value on a non-recurring basis:

 

 

 

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

 

Significant Other
Observable
Inputs (Level 2)

 

Significant
Unobservable
Inputs (Level 3)

 

Balance as of
March 31, 2013

 

Corporate loans held for investment(1)

 

$

 

$

58,423

 

$

 

$

58,423

 

Corporate loans held for sale(2)

 

 

50,068

 

3,939

 

54,007

 

Total

 

$

 

$

108,491

 

$

3,939

 

$

112,430

 

 

(1)                                 Represents loans held for investment whose carrying amount was based on estimated fair value. Of the total $58.4 million, $19.0 million was related to loans held in the Company’s allocated component of the allowance for loan losses and $39.4 million was related to loans modified in a TDR.

 

(2)                                 As of March 31, 2013, total loans held for sale had a carrying value of $107.4 million of which $54.0 million was carried at estimated fair value and the remaining $53.4 million carried at amortized cost. Of the $54.0 million carried at estimated fair value, $50.1 million was classified as Level 2 given that the assets were valued using quoted prices and other observable inputs in an active market. The remaining $3.9 million was classified as Level 3 given that the Company applied unobservable inputs based on the best available information to determine the estimated fair value. 

 

The following table presents information about the Company’s assets measured at fair value on a non-recurring basis as of December 31, 2012, and indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value (amounts in thousands). There were no liabilities measured at fair value on a non-recurring basis:

 

 

 

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

 

Significant Other
Observable
Inputs (Level 2)

 

Significant
Unobservable
Inputs (Level 3)

 

Balance as of
December 31, 2012

 

Corporate loans held for sale(1)

 

$

 

$

49,521

 

$

24,347

 

$

73,868

 

Total

 

$

 

$

49,521

 

$

24,347

 

$

73,868

 

 

(1)                                 As of December 31, 2012, total loans held for sale had a carrying value of $128.3 million of which $73.9 million was carried at estimated fair value and the remaining $54.4 million carried at amortized cost. Of the $73.9 million carried at estimated fair value, $49.5 million was classified as Level 2 given that the assets were valued using quoted prices and other observable inputs in an active market. The remaining $24.3 million was classified as Level 3 given that the Company applied unobservable inputs based on the best available information to determine the estimated fair value.

Schedule of additional information of assets measured on level 3 basis

The following table presents additional information about assets, including derivatives that are measured at fair value on a recurring basis for which the Company has utilized Level 3 inputs to determine fair value, for the three months ended March 31, 2013 (amounts in thousands):

 

 

 

Securities
Available-
For-Sale:
Corporate
Debt
Securities

 

Other
Securities,
at Estimated
Fair Value

 

Residential
Mortgage-
Backed
Securities

 

Corporate
Loans, at
Estimated
Fair Value

 

Equity
Investments,
at Estimated
Fair Value

 

Common
Stock
Warrants

 

Foreign
Exchange
Options,
Net

 

Interests in
Joint
Ventures and
Partnerships

 

Beginning balance as of January 1, 2013

 

$

42,221

 

$

2,909

 

$

83,842

 

$

16,141

 

$

97,746

 

$

1,574

 

$

8,277

 

$

142,477

 

Total gains or losses (for the period):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Included in earnings(1) 

 

(117

)

328

 

5,721

 

(1,426

)

4,516

 

245

 

(2,927

)

6,679

 

Included in other comprehensive income

 

90

 

 

 

 

 

 

 

 

Transfers into Level 3(2) 

 

 

 

 

 

 

 

 

 

Transfers out of Level 3(2) 

 

 

 

 

 

 

 

 

 

Purchases

 

 

 

 

3,073

 

 

 

 

22,812

 

Sales

 

 

 

 

 

 

 

 

 

Settlements

 

(111

)

 

(2,535

)

(463

)

 

 

 

(2,037

)

Ending balance as of March 31, 2013

 

$

42,083

 

$

3,237

 

$

87,028

 

$

17,325

 

$

102,262

 

$

1,819

 

$

5,350

 

$

169,931

 

Change in unrealized gains or losses for the period included in earnings for assets held at the end of the reporting period(1) 

 

$

(117

)

$

328

 

$

12,088

 

$

(1,722

)

$

4,516

 

$

245

 

$

(2,927

)

$

6,679

 

 

(1)                                     Amounts are included in net realized and unrealized gain on investments or net realized and unrealized (loss) gain on derivatives and foreign exchange in the condensed consolidated statements of operations.

 

(2)                                     There were no transfers between Level 1 or 2. The Company’s policy is to recognize transfers into and out of Level 3 at the end of the reporting period.

 

The following table presents additional information about assets, including derivatives that are measured at fair value on a recurring basis for which the Company has utilized level 3 inputs to determine fair value, for the three months ended March 31, 2012 (amounts in thousands):

 

 

 

Securities
Available-
For-Sale:
Corporate
Debt
Securities

 

Other
Securities,
at Estimated
Fair Value

 

Residential
Mortgage-
Backed
Securities

 

Corporate
Loans, at
Estimated
Fair Value

 

Equity
Investments,
at Estimated
Fair Value

 

Total
Rate of
Return
Swaps

 

Common
Stock
Warrants

 

Foreign
Exchange
Options,
Net

 

Other
Assets

 

Beginning balance as of January 1, 2012

 

$

67,233

 

$

2,778

 

$

86,479

 

$

 

$

150,962

 

$

152

 

$

1,266

 

$

13,394

 

$

567

 

Total gains or losses (for the period):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Included in earnings(1) 

 

550

 

(57

)

2,436

 

1,314

 

2,388

 

141

 

285

 

(1,240

)

109

 

Included in other comprehensive income

 

4,051

 

 

 

 

 

 

 

 

 

Transfers into Level 3(2) 

 

 

 

 

 

 

 

 

 

 

Transfers out of Level 3(2) 

 

 

 

 

 

 

 

 

 

 

Purchases

 

 

 

 

8,615

 

6,151

 

 

 

 

 

Sales

 

 

 

 

 

 

 

 

 

 

Settlements

 

(328

)

 

(1,552

)

 

 

 

 

 

 

 

Ending balance as of March 31, 2012

 

$

71,506

 

$

2,721

 

$

87,363

 

$

9,929

 

$

159,501

 

$

293

 

$

1,551

 

$

12,154

 

$

676

 

Change in unrealized gains or losses for the period included in earnings for assets held at the end of the reporting period(1) 

 

$

550

 

$

(57

)

$

7,798

 

$

1,314

 

$

2,388

 

$

141

 

$

285

 

$

(1,240

)

$

109

 

 

(1)                                     Amounts are included in net realized and unrealized gain on investments or net realized and unrealized (loss) gain on derivatives and foreign exchange in the condensed consolidated statements of operations.

 

(2)                                     There were no transfers between Level 1 or 2. The Company’s policy is to recognize transfers into and out of Level 3 at the end of the reporting period.

Summary of valuation techniques used for assets, measured at fair value and categorized within level 3

The following table presents additional information about valuation techniques and inputs used for assets and liabilities, including derivatives, that are measured at fair value and categorized within Level 3 as of March 31, 2013 (dollar amounts in thousands):

 

 

 

Balance as of
March 31,
2013

 

Valuation
Techniques(1)

 

Unobservable
Inputs(2)

 

Range (Weighted
Average)(3)

 

Impact to
Valuation
from an
Increase in
Input(4)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

Securities available-for-sale:

 

$

42,083

 

Yield Analysis

 

Yield

 

12% - 16% (13%)

 

Decrease

 

Corporate debt securities

 

 

 

 

 

Discount margin

 

1100bps - 1530bps

 

Decrease

 

 

 

 

 

 

 

 

 

(930bps)

 

 

 

 

 

 

 

 

 

Net leverage

 

2x - 5x (4x)

 

Decrease

 

 

 

 

 

 

 

Illiquidity discount

 

3% (3%)

 

Decrease

 

 

 

 

 

 

 

EBITDA multiple

 

7x - 8x (7x)

 

Increase

 

 

 

 

 

Broker quotes

 

Offered quotes

 

75 - 105 (89)

 

Increase

 

Other securities, at estimated fair value

 

$

3,237

 

Yield Analysis

 

Yield

 

10% (10%)

 

Decrease

 

 

 

 

 

 

 

 

Illiquidity discount

 

5% (5%)

 

Decrease

 

 

 

 

 

 

 

 

EBITDA multiple

 

7x (7x)

 

Increase

 

Residential mortgage-backed securities

 

$

87,028

 

Discounted cash flows

 

Probability of default

 

0% - 21% (6%)

 

Decrease

 

 

 

 

 

 

 

Loss severity

 

18% - 75% (32%)

 

Decrease

 

 

 

 

 

 

 

Constant prepayment rate

 

1% - 35% (14%)

 

(5)

 

Corporate loans, at estimated fair value

 

$

17,325

 

Yield Analysis

 

Illiquidity discount

 

15% (15%)

 

Decrease

 

 

 

 

 

 

 

Net leverage

 

5x - 6x (6x)

 

Decrease

 

 

 

 

 

 

 

EBITDA multiple

 

9x - 10x (9x)

 

Increase

 

 

 

 

 

Broker quotes

 

Offered quotes

 

8 - 30 (29)

 

Increase

 

Equity investments, at estimated fair value (6)

 

$

102,262

 

Market comparables

 

LTM EBITDA multiple

 

7x - 13x (11x)

 

Increase

 

 

 

 

 

 

 

Forward EBITDA multiple

 

6x - 12x (10x)

 

Increase

 

 

 

 

 

Discounted cash flows

 

Weighted average cost of capital

 

7% - 15% (10%)

 

Decrease

 

 

 

 

 

 

 

LTM EBITDA exit multiple

 

7x - 13x (9x)

 

Increase

 

Common stock warrants

 

$

1,819

 

Market comparables

 

LTM EBITDA multiple

 

6x (6x)

 

Increase

 

 

 

 

 

 

 

Forward EBITDA multiple

 

6x (6x)

 

Increase

 

 

 

 

 

 

 

Illiquidity discount

 

15% (15%)

 

Decrease

 

 

 

 

 

Discounted cash flows

 

Weighted average cost of capital

 

9% (9%)

 

Decrease

 

 

 

 

 

 

 

LTM EBITDA exit multiple

 

8x (8x)

 

Increase

 

Foreign exchange options

 

$

5,581

 

Option pricing model

 

Forward and spot rates

 

0 - 2 (1)

 

(7)

 

Interests in joint ventures and partnerships

 

$

169,931

 

Discounted cash flows

 

Illiquidity discount

 

10% - 15% (10%)

 

Decrease

 

 

 

 

 

 

 

Weighted average cost of capital

 

13% - 25% (18%)

 

Decrease

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange options

 

$

231

 

Option pricing model

 

Forward and spot rates

 

0.02 (0.02)

 

(7)

 

 

(1)                                  For the assets that have more than one valuation technique, the Company may rely on the techniques individually or in aggregate based on a weight ascribed to each one ranging from 0-100%. When determining the weighting ascribed to each valuation methodology, the Company considers, among other factors, the availability of direct market comparables, the applicability of a discounted cash flow analysis and the expected hold period and manner of realization for the investment. These factors can result in different weightings among the investments and in certain instances, may result in up to a 100% weighting to a single methodology. Broker quotes obtained for valuation purposes are reviewed by the Company through other valuation techniques.

 

(2)                                 The significant unobservable inputs used in the fair value measurement of the Company’s assets and liabilities may include the last twelve months (“LTM”) EBITDA multiple, weighted average cost of capital, discount margin, probability of default, loss severity and constant prepayment rate. In determining certain of these inputs, management evaluates a variety of factors including economic, industry and market trends and developments; market valuations of comparable companies; and company specific developments including potential exit strategies and realization opportunities. Significant increases or decreases in any of these inputs in isolation could result in significantly lower or higher fair value measurement.

 

(3)                                  Weighted average amounts are based on the estimated fair values.

 

(4)                                  Unless otherwise noted, this column represents the directional change in the fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs in isolation could result in significantly higher or lower fair value measurements.

 

(5)                                  The impact of changes in prepayment speeds may have differing impacts depending on the seniority of the instrument. Generally, an increase in the constant prepayment speed will positively impact the overall valuation of traditional mortgage assets. In contrast, an increase in the constant prepayment rate will negatively impact the overall valuation of interest-only strips.

 

(6)                                  When determining the illiquidity discount to be applied, the Company takes a uniform approach across its portfolio and generally applies a minimum 5% discount to all private equity investments carried at estimated fair value. The Company then evaluates such investments to determine if factors exist that could make it more challenging to monetize the investment and, therefore, justify applying a higher illiquidity discount. These factors generally include the salability of the investment, whether the issuer is undergoing significant restructuring activity or similar factors, as well as characteristics about the issuer including its size and/or whether it is experiencing, or expected to experience, a significant decline in earnings. Depending on the applicability of these factors, the Company determines the amount of any incremental illiquidity discount to be applied above the 5% minimum, and during the time the Company holds the investment, the illiquidity discount may be increased or decreased, from time to time, based on changes to these factors. The amount of illiquidity discount applied at any time requires considerable judgment about what a market participant would consider and is based on the facts and circumstances of each individual investment. Accordingly, the illiquidity discount ultimately considered by a market participant upon the realization of any investment may be higher or lower than that estimated by the Company in its valuations.

 

(7)                                  The directional change from an increase in forward and spot rates varies and is dependent on the specific option.

 

The following table presents additional information about valuation techniques and inputs used for assets and liabilities, including derivatives, that are measured at fair value and categorized within Level 3 as of December 31, 2012 (dollar amounts in thousands):

 

 

 

Balance as of
December 31,
2012

 

Valuation
Techniques(1)

 

Unobservable
Inputs(2)

 

Range (Weighted
Average)(3)

 

Impact to
Valuation
from an
Increase in
Input(4)

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

Securities available-for-sale:

 

$

42,221

 

Yield Analysis

 

Yield

 

11% - 46% (16%)

 

Decrease

 

Corporate debt securities

 

 

 

 

 

Discount margin

 

1100bps - 4550bps

 

Decrease

 

 

 

 

 

 

 

 

 

(1450bps)

 

 

 

 

 

 

 

 

 

Net leverage

 

3x - 13x (6x)

 

Decrease

 

 

 

 

 

 

 

Illiquidity discount

 

3% (3%)

 

Decrease

 

 

 

 

 

 

 

EBITDA multiple

 

6x - 8x (7x)

 

Increase

 

 

 

 

 

Broker quotes

 

Offered quotes

 

69 - 105 (88)

 

Increase

 

Other securities, at estimated fair value

 

$

2,909

 

Yield Analysis

 

Yield

 

10% (10%)

 

Decrease

 

Residential mortgage-backed securities

 

$

83,842

 

Discounted cash flows

 

Probability of default

 

0% - 21% (6%)

 

Decrease

 

 

 

 

 

 

 

Loss severity

 

18% - 80% (30%)

 

Decrease

 

 

 

 

 

 

 

Constant prepayment rate

 

1% - 35% (13%)

 

(5)

 

Corporate loans, at estimated fair value

 

$

16,141

 

Yield Analysis

 

Illiquidity discount

 

15% (15%)

 

Decrease

 

 

 

 

 

 

 

Net leverage

 

8x - 9x (9x)

 

Decrease

 

 

 

 

 

 

 

EBITDA multiple

 

9x - 10x (10x)

 

Increase

 

 

 

 

 

Broker quotes

 

Offered quotes

 

8 - 40 (39)

 

Increase

 

Equity investments, at estimated fair value (6)

 

$

97,746

 

Market comparables

 

LTM EBITDA multiple

 

7x - 12x (10x)

 

Increase

 

 

 

 

 

 

 

Forward EBITDA multiple

 

6x - 12x (10x)

 

Increase

 

 

 

 

 

Discounted cash flows

 

Weighted average cost of capital

 

6% - 16% (10%)

 

Decrease

 

 

 

 

 

 

 

LTM EBITDA exit multiple

 

7x - 12x (9x)

 

Increase

 

Common stock warrants

 

$

1,574

 

Market comparables

 

LTM EBITDA multiple

 

7x (7x)

 

Increase

 

 

 

 

 

 

 

Forward EBITDA multiple

 

7x (7x)

 

Increase

 

 

 

 

 

 

 

Illiquidity discount

 

15% (15%)

 

Decrease

 

 

 

 

 

Discounted cash flows

 

Weighted average cost of capital

 

12% (12%)

 

Decrease

 

 

 

 

 

 

 

LTM EBITDA exit multiple

 

7x (7x)

 

Increase

 

Foreign exchange options

 

$

8,562

 

Option pricing model

 

Forward and spot rates

 

0 - 2 (1)

 

(7)

 

Interests in joint ventures and partnerships

 

$

142,477

 

Discounted cash flows

 

Illiquidity discount

 

10% - 15% (10%)

 

Decrease

 

 

 

 

 

 

 

Weighted average cost of capital

 

13% - 30% (18%)

 

Decrease

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange options

 

$

285

 

Option pricing model

 

Forward and spot rates

 

0.02 (0.02)

 

(7)

 

 

(1)                                  For the assets that have more than one valuation technique, the Company may rely on the techniques individually or in aggregate based on a weight ascribed to each one ranging from 0-100%. When determining the weighting ascribed to each valuation methodology, the Company considers, among other factors, the availability of direct market comparables, the applicability of a discounted cash flow analysis and the expected hold period and manner of realization for the investment. These factors can result in different weightings among the investments and in certain instances, may result in up to a 100% weighting to a single methodology. Broker quotes obtained for valuation purposes are reviewed by the Company through other valuation techniques.

 

(2)                                  The significant unobservable inputs used in the fair value measurement of the Company’s assets and liabilities may include the last twelve months (“LTM”) EBITDA multiple, weighted average cost of capital, discount margin, probability of default, loss severity and constant prepayment rate. In determining certain of these inputs, management evaluates a variety of factors including economic, industry and market trends and developments; market valuations of comparable companies; and company specific developments including potential exit strategies and realization opportunities. Significant increases or decreases in any of these inputs in isolation could result in significantly lower or higher fair value measurement.

 

(3)                                  Weighted average amounts are based on the estimated fair values.

 

(4)                                  Unless otherwise noted, this column represents the directional change in the fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs in isolation could result in significantly higher or lower fair value measurements.

 

(5)                                  The impact of changes in prepayment speeds may have differing impacts depending on the seniority of the instrument. Generally, an increase in the constant prepayment speed will positively impact the overall valuation of traditional mortgage assets. In contrast, an increase in the constant prepayment rate will negatively impact the overall valuation of interest-only strips.

 

(6)                                  When determining the illiquidity discount to be applied, the Company takes a uniform approach across its portfolio and generally applies a minimum 5% discount to all private equity investments carried at estimated fair value. The Company then evaluates such investments to determine if factors exist that could make it more challenging to monetize the investment and, therefore, justify applying a higher illiquidity discount. These factors generally include the salability of the investment, whether the issuer is undergoing significant restructuring activity or similar factors, as well as characteristics about the issuer including its size and/or whether it is experiencing, or expected to experience, a significant decline in earnings. Depending on the applicability of these factors, the Company determines the amount of any incremental illiquidity discount to be applied above the 5% minimum, and during the time the Company holds the investment, the illiquidity discount may be increased or decreased, from time to time, based on changes to these factors. The amount of illiquidity discount applied at any time requires considerable judgment about what a market participant would consider and is based on the facts and circumstances of each individual investment. Accordingly, the illiquidity discount ultimately considered by a market participant upon the realization of any investment may be higher or lower than that estimated by the Company in its valuations.

 

(7)                                  The directional change from an increase in forward and spot rates varies and is dependent on the specific option.